2012 Gordon Research Conference and Gordon-Kenan Research Seminar on Plasminogen
2012年戈登纤溶酶原研究会议暨戈登-凯南研究研讨会
基本信息
- 批准号:8205335
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAlteplaseAlzheimer&aposs DiseaseAreaBasic ScienceBiologyBlood VesselsCardiovascular PhysiologyCardiovascular systemCell physiologyClinical ResearchCollaborationsDeep Vein ThrombosisDevelopmentDisciplineDiseaseEnvironmentFunctional disorderFunding ApplicantGoalsHematopoiesisHomeostasisInternationalLeadLocationMalignant NeoplasmsMediator of activation proteinMetabolismMyocardial InfarctionNatural regenerationNervous System PhysiologyNeuraxisObesityParticipantPathologic ProcessesPeptide HydrolasesPhysiological ProcessesPlasminogenPostdoctoral FellowProteolysisResearchResearch PersonnelRoleScientistStrokeSystemTissuesTranslatingTumor BiologyUnderrepresented MinorityWomanangiogenesisexperienceextracellularfrontiergraduate studenthuman diseaseinhibitor/antagonistinnovationinsightnovelnovel therapeutic interventionpeerpostersreceptorstem cell biologysymposium
项目摘要
DESCRIPTION (provided by applicant):
Funds are sought for partial support of the "Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis" (GRC), and for partial support of the associated "Gordon-Kenan Graduate Research Seminar on Plasminogen Activation and Extracellular Proteolysis" (GRS). These are paired conferences held sequentially at the same location, February 11, 12, 2012 for the GRS, and February 12-17 for the GRC. The GRC has been held continuously every two years since 1990 and enjoys an outstanding international reputation. It brings together a group of highly motivated participants with diverse scientific backgrounds that engage in intensive, yet informal, discussions at the frontier of research related to the plasminogen activation system and associated extracellular proteases in an "off-the-record" fashion. The conference thus provides a unique opportunity for the leading researchers in the world from a broad range of disciplines to present their latest unpublished research related to plasminogen activation and extracellular proteolysis, and to discuss innovative ways to translate their research into new therapies. Previous research in this area has led to the development of tissue plasminogen activator for the successful treatment of a wide range of thromboembolic disorders, and the discovery of important roles for the plasminogen activation system extracellular proteolysis in a number of physiologic and pathologic processes. Research areas to be discussed include plasminogen activation and extracellular proteolysis in vascular biology, central nervous system function and dysfunction, Alzheimer's disease, tissue homeostasis and regeneration, hematopoiesis, stem cell biology, metabolism and obesity, tumor biology, cardiovascular function, and angiogenesis. Attendees will be selected by invitation and from applications submitted online. They will be chosen to represent a diverse spectrum of researchers, and a strong emphasis will be made on the inclusion of women and underrepresented minorities as Discussion Leaders, Speakers, Poster Presenters, and Attendees. The associated GRS is a novel feature that will provide a unique opportunity for young scientists to share in the GRC experience. This two-day seminar will be organized by Graduate Students and Postdoctoral Fellows with the support of leading researchers, and will allow junior researchers within the field of plasminogen activation and extracellular proteolysis to come together to discuss their current research, while building informal networks with their peers that may lead to a lifetime of collaboration and scientific achievement.
描述(由申请人提供):
为“关于纤溶酶原激活和胞外蛋白分解的戈登研究会议”(GRC)和相关的“戈登-凯南关于纤溶酶原激活和胞外蛋白分解的研究生研究研讨会”(GRS)提供部分支持。这些是在同一地点连续举行的配对会议,2012年2月11日、12日为GRS,2月12日至17日为GRC。GRC自1990年以来每两年连续举办一次,在国际上享有盛誉。它聚集了一群具有不同科学背景的高度积极的参与者,他们在与纤溶酶原激活系统和相关的细胞外蛋白水解酶相关的研究前沿以“非正式”的方式进行密集但非正式的讨论。因此,这次会议为来自广泛学科的世界领先研究人员提供了一个独特的机会,展示他们关于纤溶酶原激活和细胞外蛋白分解的最新未发表研究,并讨论将他们的研究转化为新疗法的创新方法。组织纤溶酶原激活剂在这一领域的研究已经成功地治疗了广泛的血栓栓塞性疾病,并发现了纤溶酶原激活系统胞外蛋白分解在许多生理和病理过程中的重要作用。将讨论的研究领域包括血管生物学中的纤溶酶原激活和细胞外蛋白分解、中枢神经系统功能和功能障碍、阿尔茨海默病、组织动态平衡和再生、造血、干细胞生物学、新陈代谢和肥胖、肿瘤生物学、心血管功能和血管生成。与会者将通过邀请和在线提交的申请进行选择。他们将被选为代表不同研究人员的代表,并将大力强调将妇女和代表性不足的少数群体纳入讨论领导者、演讲者、海报主持人和与会者。相关的GRS是一项新颖的功能,将为年轻科学家提供一个分享GRC经验的独特机会。这个为期两天的研讨会将由研究生和博士后研究员在领先研究人员的支持下组织,并将允许纤溶酶原激活和细胞外蛋白分解领域的初级研究人员聚集在一起讨论他们目前的研究,同时与他们的同行建立非正式的网络,可能导致终身合作和科学成就。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADFORD S SCHWARTZ其他文献
BRADFORD S SCHWARTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADFORD S SCHWARTZ', 18)}}的其他基金
2010 Gordon Research Conference on Plasminogen Activation and Ertracellular Prote
2010年戈登纤溶酶原激活和细胞内蛋白研究会议
- 批准号:
7797041 - 财政年份:2010
- 资助金额:
$ 1万 - 项目类别:
TRITON X-100 AFFECTS THE INHIBITION OF T-PA AND U-PA BY PAI-1 DIFFERENTLY
TRITON X-100 对 PAI-1 对 T-PA 和 U-PA 的抑制产生不同影响
- 批准号:
7181245 - 财政年份:2005
- 资助金额:
$ 1万 - 项目类别:
TRITON X-100 AFFECTS THE INHIBITION OF T-PA AND U-PA BY PAI-1 DIFFERENTLY
TRITON X-100 对 PAI-1 对 T-PA 和 U-PA 的抑制产生不同影响
- 批准号:
6977631 - 财政年份:2004
- 资助金额:
$ 1万 - 项目类别:
HUMAN MONOCYTE MODULATION OF COAGULATION/FIBRINOLYSIS
人类单核细胞对凝血/纤维蛋白溶解的调节
- 批准号:
3074129 - 财政年份:1987
- 资助金额:
$ 1万 - 项目类别:
HUMAN MONOCYTE MODULATION OF COAGULATION/FIBRINOLYSIS
人类单核细胞对凝血/纤维蛋白溶解的调节
- 批准号:
3074127 - 财政年份:1987
- 资助金额:
$ 1万 - 项目类别:
HUMAN MONOCYTE MODULATION OF COAGULATION/FIBRINOLYSIS
人类单核细胞对凝血/纤维蛋白溶解的调节
- 批准号:
3074126 - 财政年份:1987
- 资助金额:
$ 1万 - 项目类别:
HUMAN MONOCYTE MODULATION OF COAGULATION/FIBRINOLYSIS
人类单核细胞对凝血/纤维蛋白溶解的调节
- 批准号:
3074125 - 财政年份:1987
- 资助金额:
$ 1万 - 项目类别:
HUMAN MONOCYTE MODULATION OF COAGULATION/FIBRINOLYSIS
人类单核细胞对凝血/纤维蛋白溶解的调节
- 批准号:
3074128 - 财政年份:1987
- 资助金额:
$ 1万 - 项目类别:
相似海外基金
AcT-Cog: Online cognitive assessment in the Alteplase compared to Tenecteplase (AcT) trial.
AcT-Cog:阿替普酶与替奈普酶 (AcT) 试验相比的在线认知评估。
- 批准号:
444794 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Operating Grants
INTERRAcT: Thrombus characteristics for predicting Reperfusion with Alteplase compared to Tenecteplase
INTERRAcT:与替奈普酶相比,阿替普酶预测再灌注的血栓特征
- 批准号:
433102 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
Operating Grants
Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke: QuICR & OPTIMISE Registry based Pragmatic Randomized Controlled Trial
阿替普酶与替奈普酶治疗急性缺血性中风患者的比较:QuICR
- 批准号:
401715 - 财政年份:2019
- 资助金额:
$ 1万 - 项目类别:
Operating Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : 1079696 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
Project Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : GNT1079696 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
Project Grants
Low-Dose Tenecteplase vs Standard-Dose Alteplase for Acute Ischaemic Stroke: An Imaging Based Safety and Efficacy Study
低剂量替奈普酶与标准剂量阿替普酶治疗急性缺血性中风:一项基于影像学的安全性和有效性研究
- 批准号:
nhmrc : 510722 - 财政年份:2008
- 资助金额:
$ 1万 - 项目类别:
NHMRC Project Grants
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8565339 - 财政年份:
- 资助金额:
$ 1万 - 项目类别:
Treament of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
7593114 - 财政年份:
- 资助金额:
$ 1万 - 项目类别:
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8952839 - 财政年份:
- 资助金额:
$ 1万 - 项目类别: